Perspective Therapeutics Inc (AMEX: CATX) is 9.45% higher on its value in year-to-date trading and has touched a low of $2.28 and a high of $19.05 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CATX stock was last observed hovering at around $3.69 in the last trading session, with the day’s gains setting it 0.71%.
Currently trading at $4.40, the stock is -50.63% and -60.54% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.8 million and changing 19.24% at the moment leaves the stock -65.33% off its SMA200. CATX registered 76.28% gain for a year compared to 6-month loss of -67.41%. The firm has a 50-day simple moving average (SMA 50) of $11.3278 and a 200-day simple moving average (SMA200) of $12.71255.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -63.06% gain in the last 1 month and extending the period to 3 months gives it a -71.15%, and is -35.10% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 26.14% over the week and 12.05% over the month.
Perspective Therapeutics Inc (CATX) has around 119 employees, a market worth around $297.39M and $8.84M in sales. Profit margin for the company is -270.46%. Distance from 52-week low is 92.98% and -76.90% from its 52-week high. The company has generated returns on investments over the last 12 months (-7.21%).
with sales reaching $232.76k over the same period.The EPS is expected to grow by 55.39% this year, but quarterly earnings will post -6.50% year-over-year. Quarterly sales are estimated to grow 104.75% in year-over-year returns.
Perspective Therapeutics Inc (CATX) Top Institutional Holders
173.0 institutions hold shares in Perspective Therapeutics Inc (CATX), with institutional investors hold 102.32% of the company’s shares. The shares outstanding are 67.59M, and float is at 49.03M with Short Float at 16.36%. Institutions hold 81.42% of the Float.
Perspective Therapeutics Inc (CATX) Insider Activity
The most recent transaction is an insider purchase by Spoor Johan M., the company’s CEO. SEC filings show that Spoor Johan M. bought 14,500 shares of the company’s common stock on Nov 25 ’24 at a price of $3.78 per share for a total of $54868.0. Following the purchase, the insider now owns 0.15 million shares.
Perspective Therapeutics Inc disclosed in a document filed with the SEC on Nov 25 ’24 that Spoor Johan M. (CEO) bought a total of 12,000 shares of the company’s common stock. The trade occurred on Nov 25 ’24 and was made at $3.80 per share for $45600.0. Following the transaction, the insider now directly holds 66600.0 shares of the CATX stock.
Still, SEC filings show that on Sep 12 ’24, Mark Austin (affiliate) Proposed Sale 2,500 shares at an average price of $15.80 for $39500.0. The insider now directly holds shares of Perspective Therapeutics Inc (CATX).
